Jeff Garro
Stock Analyst at Stephens & Co.
(0.99)
# 3,847
Out of 4,987 analysts
52
Total ratings
30.56%
Success rate
-12.03%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $22.61 | +41.53% | 4 | Sep 4, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $24.19 | +32.29% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $15.86 | +26.10% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $21.41 | +30.78% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $279.08 | +0.33% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $3.02 | +65.56% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $11.79 | +44.19% | 5 | Feb 27, 2025 | |
| EVH Evolent Health | Maintains: Equal-Weight | $16 → $12 | $8.74 | +37.30% | 5 | Jan 21, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $4.28 | +16.82% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $73.60 | -25.27% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $5.5 | $18.92 | -70.93% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $190.20 | +31.44% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $19.16 | -11.27% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $8.26 | +238.98% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $16.48 | +21.36% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $5.07 | -23.08% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $2.06 | +45.63% | 3 | May 6, 2022 |
Privia Health Group
Sep 4, 2025
Reiterates: Overweight
Price Target: $32
Current: $22.61
Upside: +41.53%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $24.19
Upside: +32.29%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $15.86
Upside: +26.10%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $21.41
Upside: +30.78%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $279.08
Upside: +0.33%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.02
Upside: +65.56%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $11.79
Upside: +44.19%
Evolent Health
Jan 21, 2025
Maintains: Equal-Weight
Price Target: $16 → $12
Current: $8.74
Upside: +37.30%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $4.28
Upside: +16.82%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $73.60
Upside: -25.27%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $18.92
Upside: -70.93%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $190.20
Upside: +31.44%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $19.16
Upside: -11.27%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $8.26
Upside: +238.98%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $16.48
Upside: +21.36%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $5.07
Upside: -23.08%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $2.06
Upside: +45.63%